- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
The Oral and Parenteral Hematinics market is a subset of the Vitamins and Dietary Supplements industry. Oral hematinics are taken orally, usually in the form of tablets, capsules, or liquids. These products are designed to help the body absorb iron, which is essential for the production of red blood cells. Parenteral hematinics are administered intravenously or intramuscularly and are used to treat iron deficiency anemia. These products are typically used in cases where oral supplementation is not effective.
The Oral and Parenteral Hematinics market is highly competitive, with a wide range of products available from various manufacturers. Companies in this market include GlaxoSmithKline, Pfizer, Merck, Sanofi, Novartis, and Bayer. Show Less Read more